These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 19496740)

  • 41. [Hypertension combination therapy with renin-angiotensin system blockers].
    Soucek M
    Vnitr Lek; 2009 Sep; 55(9):719-23. PubMed ID: 19785368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antihypertensive prescribing--a survey of general practice supervisors and registrars.
    Eastman P
    Aust Fam Physician; 2008 Nov; 37(11):969-71. PubMed ID: 19037476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hypertension in patients with diabetes].
    Poulsen PL; Hansen KW; Gaede PH; Rossing P
    Ugeskr Laeger; 2009 Jun; 171(24):2031-4. PubMed ID: 19523370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitus.
    Munger MA
    Drugs Aging; 2010 Nov; 27(11):871-83. PubMed ID: 20964461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does it matter whether patients take their antihypertensive medication as prescribed? The complex relationship between adherence and blood pressure control.
    Mant J; McManus RJ
    J Hum Hypertens; 2006 Aug; 20(8):551-3. PubMed ID: 16710290
    [No Abstract]   [Full Text] [Related]  

  • 47. Blood pressure control and physicians' therapeutic behavior in a very elderly Spanish hypertensive population.
    Rodríguez-Roca GC; Pallarés-Carratalá V; Alonso-Moreno FJ; Escobar-Cervantes C; Barrios V; Llisterri JL; Valls-Roca F; Carrasco-Martín JL; Fernández-Toro JM; Banegas JR; ;
    Hypertens Res; 2009 Sep; 32(9):753-8. PubMed ID: 19609271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adherence to antihypertensive therapy.
    Can Nurse; 2006 May; 102(5):36. PubMed ID: 16789566
    [No Abstract]   [Full Text] [Related]  

  • 49. [Knowledge transfer and implementation of clinical practice guidelines. Experience of the Canadian Hypertension Education Program].
    Poirier L; Drouin D
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S246-9. PubMed ID: 19596343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beta-blockers should remain as first-line therapy in the management of hypertension.
    Krum H
    Int J Clin Pract; 2008 Aug; 62(8):1137-41. PubMed ID: 18705818
    [No Abstract]   [Full Text] [Related]  

  • 51. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
    Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poor blood pressure control: what physicians can do to improve it.
    Rakel RR
    Postgrad Med; 2000 Oct; 108(5 Suppl):19-24. PubMed ID: 19667537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The heterogeneity of hypertension: why doesn't every patient respond to every antihypertensive drug?
    Sever P
    J Hum Hypertens; 1995 Jul; 9 Suppl 2():S33-6. PubMed ID: 7562897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination pharmacotherapy in hypertension.
    Stergiou GS
    Int Urol Nephrol; 2006; 38(3-4):673-82. PubMed ID: 17123028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
    Pareek A; Basavanagowdappa H; Zawar S; Kumar A; Chandurkar N
    Expert Opin Pharmacother; 2009 Jul; 10(10):1529-36. PubMed ID: 19514864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [No response to antihypertensive therapy: consider non-adherence].
    de Vaan HH
    Ned Tijdschr Geneeskd; 2007 Jun; 151(25):1434-5; author reply 1435. PubMed ID: 17668611
    [No Abstract]   [Full Text] [Related]  

  • 57. Adherence to antihypertensive medications: is prescribing the right pill enough?
    Gosmanova EO; Kovesdy CP
    Nephrol Dial Transplant; 2015 Oct; 30(10):1649-56. PubMed ID: 25335506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rationale for triple-combination therapy for management of high blood pressure.
    Gradman AH
    J Clin Hypertens (Greenwich); 2010 Nov; 12(11):869-78. PubMed ID: 21054774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of the content of the knowledge on adherence to medication in hypertensive patients.
    Karaeren H; Yokuşoğlu M; Uzun S; Baysan O; Köz C; Kara B; Kirilmaz A; Naharci I; Pinar M; Yilmaz MB; Uzun M
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):183-8. PubMed ID: 19520651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
    Cortez-Dias N; Martins S; Belo A; Fiuza M;
    Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.